It wouldn’t matter the total volume in sales . It could be $10b . If retailers are cut to the bone it’s a loss making exercise . The only winner with Nuvaring Generic was First to Market. So Scott gets it right this time. Even his statement says affordable. It is to the consumer but like all Generics now a Loss making exercise .
MYX Price at posting:
34.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)